Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

Aceragen Inc (ACGN)

  • Technical Exchange News
  • Jan. 31, 2024, 05:22 UTC
  • 30
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Aceragen, Inc. - Common Stock.

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • Jan. 30, 2024, 19:09 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Universe Pharmaceuticals Inc. (UPC)

  • Technical Exchange News
  • Jan. 30, 2024, 18:51 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Qiagen N.V. (QGEN)

  • Technical Exchange News
  • Jan. 30, 2024, 00:34 UTC
  • 31
  • 0 comments

NYSE traded attribute type Security_Name was changed. Previous value: Qiagen N.V. Common Shares . New value: Qiagen N.V. Common Shares.

Comment Full text

Qiagen N.V. (QGEN)

  • Technical Exchange News
  • Jan. 30, 2024, 00:30 UTC
  • 31
  • 0 comments

NYSE symbol attribute type Security_Name was changed. Previous value: Qiagen N.V. Common Shares . New value: Qiagen N.V. Common Shares.

Comment Full text

Windtree Therapeutics Inc. (WINT)

  • Technical Exchange News
  • Jan. 29, 2024, 18:47 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

eFFECTOR Therapeutics Inc. (EFTR)

  • Technical Exchange News
  • Jan. 29, 2024, 18:46 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Windtree Therapeutics Inc. (WINT)

  • Technical Exchange News
  • Jan. 29, 2024, 18:46 UTC
  • 33
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

eFFECTOR Therapeutics Inc. (EFTR)

  • Technical Exchange News
  • Jan. 29, 2024, 18:45 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Zynex Inc (ZYXI)

  • Technical Exchange News
  • Jan. 28, 2024, 23:25 UTC
  • 32
  • 0 comments

NASDAQ traded attribute type Security_Name was changed. Previous value: -. New value: Zynex, Inc. - Common Stock.

Comment Full text
  • Previous
  • 707
  • 708
  • 709
  • 710
  • 711
  • Next

Search

News categories

  • Technical Exchange News(10969)
  • Event(2438)
  • SEC News(193333)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(125869)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin